OA22.06 Changes in Cognition after Osimertinib, with or without SRS, in EGFRm NSCLC with Brain Metastases: a Pooled Analysis of RCTs.

Autor: Soon, Y.Y., Lefresne, S., Robledo, K., Nichol, A., Pinkham, M., Sahgal, A., Lee, C.K., Parmar, A., Huang, Y., Doherty, M., Solomon, B., Shultz, D., Tham, I.W.K., Sacher, A., Tey, J.C.S., Leong, C.N., Koh, W.Y., Ang, Y., Low, J., Yong, C.
Zdroj: Journal of Thoracic Oncology; 2023 Supplement, Vol. 18 Issue 11, pS97-S97, 1p
Databáze: Complementary Index